首页|期刊导航|Cancer Innovation|Combining Small-Molecular Compounds With CAR T-Cell Therapy:Novel Strategies for Enhanced Cancer Immunotherapy

Combining Small-Molecular Compounds With CAR T-Cell Therapy:Novel Strategies for Enhanced Cancer ImmunotherapyOA

中文摘要

Chimeric antigen receptor(CAR)T-cell therapy has been proved to be an effective cancer immunotherapy strategy against haematological malignancies,but exhaustion,limited persistence,and treatment-related toxicity have been identified as major roadblocks in solid tumour treatment.Small-molecular compounds could effectively improve CAR T-cell therapy,such as preventing exhaustion,enhancing memory formation,and enhancing the antitumor activity.Additionally,adding small molecule switches based on tetracycline-controlled gene expression system is an effective strategy to improve the safety of CAR T therapy and reduce its side effects.Despite the encouraging preclinical and clinical results,challenges still remain in optimizing dosing regimens and managing drug interactions.This review aims to summarize recent advances in combined approach and to discuss the underlying mechanisms of its potential benefits.

Rangzi Yi;Zijian Zhang;Yang Yang;Haichuan Zhu

Department of Endocrinology,Tianyou Hospital,School of Medicine,Wuhan University of Science and Technology,Wuhan,Hubei,ChinaNational“111”Center for Cellular Regulation and Molecular Pharmaceutics,Key Laboratory of Fermentation Engineering(Ministry of Education),Hubei University of Technology,Wuhan,Hubei,ChinaDepartment of Endocrinology,Tianyou Hospital,School of Medicine,Wuhan University of Science and Technology,Wuhan,Hubei,ChinaNational“111”Center for Cellular Regulation and Molecular Pharmaceutics,Key Laboratory of Fermentation Engineering(Ministry of Education),Hubei University of Technology,Wuhan,Hubei,China

医药卫生

CAR Tcombined therapyimmunotherapymolecular compoundT-cell exhaustion

《Cancer Innovation》 2026 (2)

P.14-38,25

National Natural Science Foundation of China,Grant/Award Number:8257022Hubei Provincial Natural Science Foundation(Young Talents Project,Class A),Grant/Award Number:JCZRJQ202500008S&T Program of Xiongan New Area,Grant/Award Number:XA202501102002KNatural Science Foundation of Chongqing,Grant/Award Numbers:CSTB2024NSCQ-MSX0066,CSTB2024NSCQ-MSX0238Startup Fund of Hubei University of Technology,Grant/Award Number:25004Beijing Dadi Medical Charity FoundationBeijing Bethune Charity Foundation,Grant/Award Number:2023-YJ-152-J-027。

10.1002/cai2.70053

评论